Celadon Pharmaceuticals

London, United Kingdom

Celadon's objective is to improve the quality of life for the most vulnerable people by producing cannabis-based medications.

$2.6M raised

May 2024

Post-IPO Equity

Biopharma Biotechnology Cannabis Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Celadon Pharmaceuticals

How much funding has Celadon Pharmaceuticals raised?

Celadon Pharmaceuticals has raised $2.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2024.

Where is Celadon Pharmaceuticals headquartered?

Celadon Pharmaceuticals is headquartered in London, United Kingdom.

What does Celadon Pharmaceuticals do?

Celadon's objective is to improve the quality of life for the most vulnerable people by producing cannabis-based medications.

What stage is Celadon Pharmaceuticals at?

Celadon Pharmaceuticals is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 10, 2024.

MLA

"Celadon Pharmaceuticals — Funding & Investors." VCBacked, May 10, 2024, https://www.vcbacked.co/company/celadon-pharmaceuticals. Accessed July 3, 2026.

APA

VCBacked. (2024). Celadon Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/celadon-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Celadon Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/celadon-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 10, 2024.